Results per Page:
$5.25M from the Kuni Foundation propels innovative adult oncology research
Grants will support research on tumor regression, immunotherapy access and better care for breast, liver and peritoneal malignancies
Diagnosed with stage 4 kidney cancer, a woman is disease-free after immunotherapy
Treatment includes a unique approach to reduced-frequency dosing
Reducing frequency of immunotherapy dosing could save money and time, keep patients on therapy longer
Study of immune checkpoint inhibitor dosing in patients with advanced skin cancers could help guide long-term treatment plans